biospecimen banks

WRNMMC UsToo! Newsletter

 

Current Newsletter - AUGUST 2014, Volume 23 Issue 3

After eleven years of the WRNMMC Prostate Cancer Newsletter distributed in hard copy via the US Postal Service, the newsletter is now completely "digital," and posted exclusively to the CPDR web site.

The WRNMMC US TOO Newsletter started as an eight page publication intended for the military prostate cancer community in the Greater Washington, D.C. metropolitan area. It grew rapidly under the leadership of the late Bob Zveare, the founding editor. Initially printed in 200 copies for local distribution, it is now digitally distributed far beyond "the Beltway."

The Newsletter is produced and distributed quarterly without charge to the expanded readership. Corporate grants and individual donations from the readership provide the financial wherewithal to sustain the operation. There are no paid employees. Instead, the Newsletter relies on volunteer effort from within the WRNMMC US TOO board of directors for its operation. The respective staffs of the WRNMMC Urology Service and the Department of Defense Center for Prostate Disease Research (CPDR) also provide support and encouragement.

 

Newsletter Archive

Index of Past Issues

May 2014, Volume 23 Issue 2

February 2014, Volume 23 Issue 1

November 2013, Volume 22 Issue 4

August 2013, Volume 22 Issue 3

May 2013, Volume 22 Issue 2

February 2013, Volume 22 Issue 1

November 2012, Volume 21 Issue 4

August 2012, Volume 21 Issue 3

May 2012, Volume 21 Issue 2

February 2012, Volume 21 Issue 1

November 2011, Volume 20 Issue 3

August 2011, Volume 20 Issue 2

May 2011, Volume 20 Issue 1

August 2010, Volume 19 Issue 2

February 2010, Volume 19 Issue 1

November 2009, Volume 18 Issue 4<br>

August 2009, Volume 18 Issue 3

May 2009, Volume 18 Issue 2

February 2009, Volume 18 Issue 1

November 2008, Volume 17 Issue 4

August 2008, Volume 17 Issue 3

May 2008, Volume 17 Issue 2

February 2008, Volume 17 Issue 1

November 2007, Volume 16 Issue 4

August 2007, Volume 16 Issue 3

May 2007, Volume 16 Issue 2

February 2007, Volume 16 Issue 1

November 2006, Volume 15 Issue 4

August 2006, Volume 15 Issue 3

May 2006, Volume 15 Issue 2

February 2006, Volume 15 Issue 1

November 2005, Volume 14 Issue 4

August 2005, Volume 14 Issue 3

May 2005, Volume 14 Issue 2

February 2005, Volume 14 Issue 1

November 2004, Volume 13 Issue 4

August 2004, Volume 13 Issue 3

May 2004, Volume 13 Issue 2

February 2004, Volume 13 Issue 1

November 2003, Volume 12 Issue 4

August 2003, Volume 12 Issue 3

 

 

CURRENT EVENTS


August 21, 2014

ERG Monoclonal Antibody [9FY] Patent Issued To The Uniformed Services University Of The Health Sciences Center For Prostate Disease Research & Biocare Medical

Concord, CA – The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has been awarded a patent in the United States (Patent No: US 8,765,916 B2) and Europe for ERG monoclonal antibodies. The patent is pending in Australia, Canada and Japan. ERG mouse antibody 9FY is a rigorously characterized antibody for its specificity of the ERG protein detection among the closely related members of the ETS transcription factor family in biological specimens.

Read Full Article

 

August 6, 2014

Genomic Health Announces Positive Topline Results of Additional, Large Independent Validation Study of Oncotype DX® Prostate Cancer Test with Multiple Clinical Endpoints

Redwood City, CA – PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the Oncotype DX® Genomic Prostate Score (GPS) predicts multiple clinical endpoints related to disease aggressiveness in men with low- and intermediate-risk prostate cancer. This study validated the Oncotype DX prostate cancer test as a ...

Read Full Article

 

WRNMMC UsToo! Newsletter

Read the AUGUST 2014 Newsletter